Identification of a shared F8 mutation in the Korean patients with acquired hemophilia A

Korean Journal of Hematology

Volumn 46, Issue 1, 2011, Pages 49-51

  Hwang, Sung Ho ^a   Lim, Jeong A ^a   Kim, Hugh Chul ^b   Lee, Hyun Woo ^b   Kim, Hye Sun ^a  

^a Kyungpook National University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Acquired haemophilia A; Haemophilia A; Mutation profiling; Sequence variation

Indexed keywords

EID: 83555170287     PISSN: 17387949     EISSN: 20929129     Source Type: Journal    
DOI: 10.5045/kjh.2011.46.1.49     Document Type: Article

References (15)

1. Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003;121:21-35.
2. Boggio LN, Green D. Acquired hemophilia. Rev Clin Exp Hematol 2001;5:389-404.
3. Collins PW, Hirsch S, Baglin TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 2007;109:1870-7.
4. Fidanci ID, Kavakli K, Uçar C, et al. Factor 8 (F8) gene mutation profile of Turkish hemophilia A patients with inhibitors. Blood Coagul Fibrinolysis 2008;19:383-8.
5. Oldenburg J, Pavlova A. Genetic risk factors for inhibitors to factors VIII and IX. Haemophilia 2006;12(Suppl 6):15-22.
6. Hwang SH, Kim MJ, Lim JA, Kim HC, Kim HS. Profiling of factor VIII mutations in Korean haemophilia A. Haemophilia 2009; 15:1311-7.
7. Tiede A, Eisert R, Czwalinna A, Miesbach W, Scharrer I, Ganser A. Acquired haemophilia caused by non-haemophilic factor VIII gene variants. Ann Hematol 2010;89:607-12.
8. Deichmann K, Heinzmann A, Brüggenolte E, Forster J, Kuehr J. An Mse I RFLP in the human CTLA4 promotor. Biochem Biophys Res Commun 1996;225:817-8.
9. Ueda H, Howson JM, Esposito L, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003;423:506-11.
10. Donner H, Rau H, Walfish PG, et al. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1997;82:143-6.
11. Oldenburg J, Zeitler H, Pavlova A. Genetic markers in acquired haemophilia. Haemophilia 2010;16(Suppl 3):41-5.
12. Di Marco S, Hel Z, Lachance C, Furneaux H, Radzioch D. Polymorphism in the 3'-untranslated region of TNFalpha mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFalpha mRNA. Nucleic Acids Res 2001;29:863-71.
13. Di Paola R, Frittitta L, Miscio G, et al. A variation in 3' UTR of hPTP1B increases specific gene expression and associates with insulin resistance. Am J Hum Genet 2002;70:806-12.
14. Vielhaber E, Jacobson DP, Ketterling RP, Liu JZ, Sommer SS. A mutation in the 3' untranslated region of the factor IX gene in four families with hemophilia B. Hum Mol Genet 1993;2:1309-10.
15. de la Salle C, Charmantier JL, Baas MJ, et al. A deletion located in the 3' non translated part of the factor IX gene responsible for mild haemophilia B. Thromb Haemost 1993;70:370-1.